Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers
Molecular Cancer · Published 2026-07-31 · DOI 10.1186/s12943-026-02744-0
Free full text
Authors (32)
Claudia Manriquez-Roman, Elizabeth L. Siegler, Justyna J. Gleba, Truc N. Huynh, Grace E. DeFranco, Aylin Alasonyalilar Demirer, Matthew L. Pawlush, Michael Redig, Skyeler M. Klinge, Long K. Mai, James L. Miller, Erin E. Miller, Brooke L. Kimball, Erin E. Tapper, R. Leo Sakemura, Carli M. Stewart, Ismail Can, Olivia L. Sirpilla, Jennifer M. Feigin, Kun Yun, Omar L. Gutierrez-Ruiz, Hong Xia, Mehrdad Hefazi, Kendall J. Schick, Ekene J. Ogbodo, Gloria Olivier, Yushi Qiu, Robert C. Smallridge, Abba Zubair, Han W. Tun, John A. Copland, Saad S. Kenderian
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Manriquez-Roman, C., Siegler, E., Gleba, J., et al. (2026). Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers. Molecular Cancer. https://doi.org/10.1186/s12943-026-02744-0
Related articles
- AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia · Molecular Cancer · 2026 · Same journal
- Breaking the immune “cold niche” in bone metastasis: core mechanisms of the multidimensional interwoven regulatory network and precision breakthrough strategies · Molecular Cancer · 2026 · Same journal
- Landscape of T-cell bispecific antibodies in cancer therapy: therapeutic strategies, challenges and future prospection · Molecular Cancer · 2026 · Same journal
- Trace elements and tumors: homeostatic networks, molecular mechanisms and new horizons for precision intervention · Molecular Cancer · 2026 · Same journal
- Autophagy in cancer — functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive review · Molecular Cancer · 2026 · Same journal
- Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma · Molecular Cancer · 2026 · Same journal
- Reprogramming the pancreatic ductal adenocarcinoma microenvironment: a novel integrin-targeted cytotoxin, ProAgio, potentiates chemotherapy · Molecular Cancer · 2026 · Same journal
- ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer · Molecular Cancer · 2026 · Same journal
- Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives · Molecular Cancer · 2026 · Same journal
- The influence of hypoxia on cancer lipid metabolism: a scoping review · Molecular Cancer · 2026 · Same journal